About Yehuda Handelsman, M.D., F.A.C.P., F.A.C.E., F.N.L.A.

Yehuda Handelsman, MD, FACP, FACE, FNLA is an endocrinologist in solo private practice in Tarzana, California, where he developed and successfully utilizes a comprehensive and unique, multiple interventions approach in the cardio-metabolic high risk patient, preventing & managing obesity, Diabetes & cardiovascular disease. He is Medical Director & Principal Investigator of the Metabolic Institute of America. He has been listed repeatedly in “Top Doctors of Los Angeles” & “Southern California Super Doctors”. Chair and Program Director of the Annual World Congress on the Insulin Resistance, Diabetes & cardiovascular disease; Chair and founder of the International Committee for Insulin Resistance and Senior Scientific Consultant for the Metabolic Endocrine Education Foundation.

Dr. Handelsman is President elect and executive board member of the American Association of Clinical Endocrinology (AACE), recently he served secretary, treasurer & trustee of the America College of Endocrinology. He has performed multiple tasks on behalf of AACE as chair and a member of many committees, task forces, guidelines and consensus positions; listing a few: co-chair 2011 Diabetes guideline committee, chair AACE Diabetes council, member Diabetes Treatment Algorithm 2009; Lipids Guidelines 2011, Diabetes roadmap 2007; chair, task force to create standards for insulin pumps & a member of the 2010 published position on insulin Pump management; Past Chair AACE annual meeting, an ongoing adviser to the Annual program committee. Chair & Founder.  National Initiative- Diabetes Education for Primary Care Physician; Chair National Initiative for Education & Compassionate Treatment of Lipodysrophy. Co-Chair “the Management of Pre Diabetes” a Consensus Position of the American College of Endocrinology. Adviser to “AACE visiting Professorship for academic medical center”; a reviewer- AACE HTN guideline. Past President & founder, California Chapter of AACE. Dr Handelsman is a board member of the Pacific Lipid Association, he has been a member of Steering Committees of Clinical research in diabetes and lipid disorders. 

Handelsman is associate Editor, “Journal of Diabetes” an International peer reviewed journal, based in China, devoted to diabetes research, therapeutics and education; he frequently serves as guest editor of multiple publications, recently for “Journal of Clinical Hypertension” (JCH), “Metabolic Syndrome and related disorders” and “Postgraduate Medicine. He is “Executive Editor” of the “Journal of Diabetes and Metabolism- Open Access” OMICS Publishing Group, Stanford California; An editorial board member of “Clinical Endocrine News” and a reviewer for journals on Diabetes, lipids, HTN, Metabolism, Obesity, nutrition and General Endocrinology; he consultants to publications on drugs and therapeutics.

Dr. Handelsman is a summa cum laude graduate of the University of the Pacific, in Stockton, California.  He is a Fellow of the American College of Endocrinology, the American College of Physicians and the National Lipid Association. Dr. Handelsman earned his doctor of medicine degree from Tel Aviv University Sackler Faculty of Medicine in Israel. He completed a subsequent internship and residency in internal medicine at New York Infirmary Beekman Downtown Hospital under New York University. His fellowship in diabetes and endocrinology was conducted at the University of Southern California Medical School in Los Angeles.

Dr. Handelsman is a member of such professional organizations as American College of Endocrinology, American Association of Clinical Endocrinologists, American Diabetes Association, National Lipid Association, American Thyroid Association, Academy of Thyroidologists, American College of Physicians, National Osteoporosis Foundation, Los Angeles & California Medical Associations and American Medical Association.

A clinician, researcher and educator Dr. Handelsman is a recognized authority, on Diabetes, insulin resistance, metabolic syndrome, pre-diabetes, gut hormones & multi-hormonal Obesity. He is a leader in the comprehensive approach to the treatment of Diabetes, utilizing combination therapy in controlling all cardiovascular risks in the prevention of complications & cardiovascular disease. He has been a national and international consultant, lecturer and has published extensively on diabetes, hypertension, lipids disorders, obesity, insulin resistance, metabolic syndrome, pre-diabetes, comprehensive treatment of diabetes, Insulin, Incretins and gut Hormones. He has also consulted and lectured on lipodystrophy, thyroid and osteoporosis.